Antibacterial Activity of Functionalized Dihydropyrimidines
申请人:WiSys Technology Foundation, Inc.
公开号:US20220220082A1
公开(公告)日:2022-07-14
Emmacin-related substituted dihydropyrimidine compounds demonstrate potency at low concentrations and inhibit Methicillin-resistant
S. aureus
growth. One such compound is:
Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis
作者:Emma E. Wyatt、Warren R. J. D. Galloway、Gemma L. Thomas、Martin Welch、Olivier Loiseleur、Alleyn T. Plowright、David R. Spring
DOI:10.1039/b812901k
日期:——
The screening of a diversity-orientedsynthesis library followed by structure-activity relationship investigations have led to the discovery of an anti-MRSAagent which operates as an inhibitor of Staphylococcus aureus dihydrofolate reductase.